Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Multiple sclerosis: Could Helicobacter pylori provide protection against multiple sclerosis?
Women's Issues in Multiple Sclerosis.
Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Risk factors for convertion to clinically defined multiple sclerosis after clinically isolated syndrome in a racially mixed Brazilian cohort.
Susceptibility tensor imaging (STI) of the brain.
Neurological involvement in Primary Sjögren Syndrome.
The effects of prolonged wear of textured shoe insoles on gait, foot sensation and proprioception in people with multiple sclerosis: study protocol for a randomised controlled trial.
Reassessing the risk of natalizumab-associated PML.
Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosis.
CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma.
Multiple Sclerosis: Modulation of Toll-Like Receptor (TLR) Expression by Interferon-β Includes Upregulation of TLR7 in Plasmacytoid Dendritic Cells.
Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells.
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.
Effects of dimethyl fumarate on lymphocyte subsets.
WT1 and interferon-β-vitamin D association in MS: a longitudinal study.
Evaluation of quality of life and fatigue in radiologically isolated syndrome.
Population pharmacokinetics of ponesimod and its primary metabolites in healthy and organ-impaired subjects.
Dimethyl fumarate protection against collagen II degradation.
Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-γ and interleukin-4 response.
Glatiramer acetate induced hepatotoxicity.
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis.
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses.
Diagnosis and treatment of hyponatraemia.
Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer's disease.
Policy: NIH to balance sex in cell and animal studies.

Pages